Literature DB >> 21160859

Clinicopathologic and immunohistochemical profile of ovarian metastases from colorectal carcinoma.

Gozde Kir1, Ayse Gurbuz, Ates Karateke, Mustafa Kir.   

Abstract

Metastasis of colorectal adenocarcinoma of the ovary is not an uncommon occurrence and ovarian metastases from colorectal carcinoma frequently mimic endometrioid and mucinous primary ovarian carcinoma. The clinical and pathologic features of metastatic colorectal adenocarcinoma involving the ovary is reviewed with particular focus on the diagnostic challenge of distinguishing these secondary ovarian tumors from primary ovarian neoplasm. Immunohistochemical stains that may be useful in the differential diagnosis of metastatic colorectal tumors to the ovary and primary ovarian tumors are detailed.

Entities:  

Keywords:  Colon; Colorectal carcinoma; Endometrioid adenocarcinoma; Immunohistochemistry; Metastatic carcinoma; Mucinous carcinoma; Ovary

Year:  2010        PMID： 21160859      PMCID： PMC2999225          DOI： 10.4240/wjgs.v2.i4.109

Source DB:  PubMed          Journal:  World J Gastrointest Surg


  82 in total

1.  Ovarian involvement by metastatic colorectal adenocarcinoma: still a diagnostic challenge.

Authors:  Michael R Lewis; Michael T Deavers; Elvio G Silva; Anais Malpica
Journal:  Am J Surg Pathol       Date:  2006-02       Impact factor: 6.394

2.  Oophorectomy during surgery for colorectal carcinoma.

Authors:  A Tentes; S Markakidis; C Mirelis; C Leventis; K Mitrousi; A Gosev; C Kaisas; Y Bouyioukas; A Xanthoulis; O Korakianitis
Journal:  Tech Coloproctol       Date:  2004-11       Impact factor: 3.781

3.  Accuracy of frozen section in distinguishing primary ovarian neoplasia from tumors metastatic to the ovary.

Authors:  Colin J R Stewart; Barbara A Brennan; Ian G Hammond; Yee C Leung; Anthony J McCartney
Journal:  Int J Gynecol Pathol       Date:  2005-10       Impact factor: 2.762

4.  Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7.

Authors:  Russell Vang; Allen M Gown; Lee-Shu-Fune Wu; Todd S Barry; Darren T Wheeler; Anna Yemelyanova; Jeffrey D Seidman; Brigitte M Ronnett
Journal:  Mod Pathol       Date:  2006-09-15       Impact factor: 7.842

5.  Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma.

Authors:  Sanjay Logani; Esther Oliva; Paula M Arnell; Mahul B Amin; Robert H Young
Journal:  Mod Pathol       Date:  2005-01       Impact factor: 7.842

6.  Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.

Authors:  Jesse K McKenney; Robert A Soslow; Teri A Longacre
Journal:  Am J Surg Pathol       Date:  2008-05       Impact factor: 6.394

7.  Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification.

Authors:  Anna V Yemelyanova; Russell Vang; Kara Judson; Lee-Shu-Fune Wu; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2008-01       Impact factor: 6.394

8.  Malignant tumors metastatic to the ovaries.

Authors:  A Ayhan; Z S Tuncer; O Bükülmez
Journal:  J Surg Oncol       Date:  1995-12       Impact factor: 3.454

9.  Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement.

Authors:  Kara Judson; Colleen McCormick; Russell Vang; Anna V Yemelyanova; Lee-Shu-Fune Wu; Robert E Bristow; Brigitte M Ronnett
Journal:  Int J Gynecol Pathol       Date:  2008-04       Impact factor: 2.762

10.  CDX-2 immunostaining in primary and secondary ovarian carcinomas.

Authors:  L Tornillo; H Moch; P-A Diener; A Lugli; G Singer
Journal:  J Clin Pathol       Date:  2004-06       Impact factor: 3.411
View more
  5 in total

1.  The clinical significance of occult gynecologic primary tumours in metastatic cancer.

Authors:  M B Hannouf; E Winquist; S M Mahmud; M Brackstone; S Sarma; G Rodrigues; P K Rogan; J S Hoch; G S Zaric
Journal:  Curr Oncol       Date:  2017-10-25       Impact factor: 3.677

Review 2.  Prognosis and factors affecting colorectal cancer with ovarian metastasis.

Authors:  Fangyue Zhou; Jingxin Ding
Journal:  Updates Surg       Date:  2021-02-01

Review 3.  Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review.

Authors:  Megan A Murphy; Britton Trabert; Hannah P Yang; Yikyung Park; Louise A Brinton; Patricia Hartge; Mark E Sherman; Albert Hollenbeck; Nicolas Wentzensen
Journal:  Cancer Causes Control       Date:  2012-09-13       Impact factor: 2.506

4.  Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health Study.

Authors:  Hannah P Yang; Britton Trabert; Megan A Murphy; Mark E Sherman; Joshua N Sampson; Louise A Brinton; Patricia Hartge; Albert Hollenbeck; Yikyung Park; Nicolas Wentzensen
Journal:  Int J Cancer       Date:  2011-11-10       Impact factor: 7.396

5.  Immunohistochemical Characterization of Normal Ovary and Common Epithelial Ovarian Neoplasm with a Monoclonal Antibody to Cytokeratin and Vimentin.

Authors:  Ankita Goel; Nandam Mohan Rao; Vissa Santhi; Syam Sundar Byna; Bhavana Grandhi; Jyothi Conjeevaram
Journal:  Iran J Pathol       Date:  2018
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.